V Seshiah
Overview
Explore the profile of V Seshiah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
751
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sharma S, Seshiah V, Sahay B, Das A, Rao P, Shah S, et al.
Indian J Endocrinol Metab
. 2013 Apr;
16(Suppl 2):S471-3.
PMID: 23565470
Introduction: The IMPROVE Control Training program was designed by Indian Academy of Diabetes (IAD), and a non-intervention study was conducted to evaluate the effectiveness of this standardized healthcare professionals (HCPs)...
12.
Anand Moses C, Seshiah V, Sahay B, Kumar A, Asirvatham A, Balaji V, et al.
Indian J Endocrinol Metab
. 2013 Apr;
16(Suppl 2):S432-3.
PMID: 23565455
Introduction: Improving management practices and clinical outcomes in type 2 diabetes (IMPACT), was a prospective, open-label, 26- week, comparative, multi-center study to compare efficacy and safety of the Indian insulin...
13.
Das A, Seshiah V, Sahay B, Kumar A, Asirvatham A, Balaji V, et al.
Indian J Endocrinol Metab
. 2013 Apr;
16(Suppl 2):S430-1.
PMID: 23565454
Introduction: Diabetes is the fourth leading cause of disease-related death and almost 80% of diabetes-related deaths occur in developing countries. Optimal glycemic control, in particular HbA1c level less than 7%...
14.
Kalra S, Moses C, Seshiah V, Sahay B, Kumar A, Asirvatham A, et al.
Indian J Endocrinol Metab
. 2013 Apr;
16(Suppl 2):S426-7.
PMID: 23565452
Introduction: The effectiveness and impact of the Indian insulin guideline in clinical practice was evaluated by the Improving Management Practices and Clinical Outcomes in Type 2 Diabetes (IMPACT) Study. The...
15.
Seshiah V, Balaji V
J Assoc Physicians India
. 2013 Feb;
60:33-4, 39.
PMID: 23409419
No abstract available.
16.
Seshiah V, Balaji V, Shah S, Joshi S, Das A, Sahay B, et al.
J Assoc Physicians India
. 2013 Feb;
60:15-7.
PMID: 23405515
Background And Objective: Diabetes in Pregnancy Study Group India (DIPSI) recommends 2-h Plasma glucose (PG) > or = 140 mg/dL with 75g oral glucose load to diagnose GDM, akin to...
17.
McIntyre H, Oats J, Zeck W, Seshiah V, Hod M
Int J Gynaecol Obstet
. 2011 Nov;
115 Suppl 1:S26-9.
PMID: 22099436
The International Association of the Diabetes and Pregnancy Study Groups' (IADPSG) criteria for the diagnosis and classification of hyperglycemia in pregnancy are described and application of these in differing healthcare...
18.
Magon N, Seshiah V
Indian J Endocrinol Metab
. 2011 Oct;
15(4):284-93.
PMID: 22028999
Gestational diabetes mellitus (GDM) complicates a substantial number of pregnancies. There is consensus that in patients of GDM, excellent blood glucose control, with diet and, when necessary, oral hypoglycemics and...
19.
Balaji V, Balaji M, Anjalakshi C, Cynthia A, Arthi T, Seshiah V
Indian J Endocrinol Metab
. 2011 Sep;
15(3):187-90.
PMID: 21897895
Objective: To assess the validity of Diabetes in Pregnancy Study Group India (DIPSI) guidelines, a modified version of the WHO criterion to diagnose gestational diabetes mellitus (GDM). Materials And Methods:...
20.
Inadequacy of fasting plasma glucose to diagnose gestational diabetes mellitus in Asian Indian women
Balaji V, Balaji M, Anjalakshi C, Cynthia A, Arthi T, Seshiah V
Diabetes Res Clin Pract
. 2011 Aug;
94(1):e21-3.
PMID: 21831468
The prevalence of Gestational Diabetes Mellitus (GDM) diagnosed by WHO criterion (2-hPG ≥ 7.8 mmol/L) was 13.4%. By International Association of Diabetes and Pregnancy Study Groups criteria of FPG ≥...